Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Oct 12, 2021 (5 years ago)

Tri-Mix Papaverine 30/Phentolamine 2/Pge-1 40 Inj Injectable

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of assurance of sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

TRI-MIX PAPAVERINE 30/PHENTOLAMINE 2/PGE-1 40 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Drug: Papaverine

Recalling firm
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Origin
TX, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0213-2022 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Papaverine recalls

See all
Class I · High risk

Papaverine HCl Injection

Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde

Ongoing Particulate / foreign matter American Regent, Inc. NDC 0517-4002-01 D-0800-2026

Other recalls by Vita Pharmacy, LLC dba Talon Compounding Pharmacy

All 2021 recalls